Tech Investment News
- Big Tech Faces Big Test on ESG Issues - AllianceBernstein July 15, 2024Big Tech Faces Big Test on ESG Issues AllianceBernstein
- Technology, Media & Communications Conference - JP Morgan May 22, 2024Technology, Media & Communications Conference JP Morgan
- International Media Investments appoints Bradley Eliot as Chief Technology Officer - Intelligent CIO May 20, 2024International Media Investments appoints Bradley Eliot as Chief Technology Officer Intelligent CIO
- Tech, Media & Telecom Roundup: Market Talk - The Wall Street Journal May 9, 2024Tech, Media & Telecom Roundup: Market Talk The Wall Street Journal
- Small-time investors in Trump’s Truth Social reckon with stock collapse - The Washington Post April 14, 2024Small-time investors in Trump’s Truth Social reckon with stock collapse The Washington Post
- Big Tech Faces Big Test on ESG Issues - AllianceBernstein July 15, 2024
Tag Archives: Robert Lanza
New Stem Cell Therapy Trial Approved
Another human embryotic stem cell therapy has been approved for clinical trials. Advanced Cell Technology Inc. announced that the Food and Drug Administration has approved the Phase I/II trial of retinal cells for Stargardt’s Macular Dystrophy patients. This condition is … Continue reading
Posted in Technology
Tagged Advanced Cell Technology Inc., retinal pigment epithelium, Robert Lanza, Stargardt’s Macular Dystrophy
Comments Off on New Stem Cell Therapy Trial Approved